Covenant Partners’s Thermo Fisher Scientific TMO Stock Holding History

Covenant Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,344	Closed	-$779K	–	123
2025 Q4	$779K	Buy	1,344 +15	+1%	+$8.48K	0.23%	46
2025 Q3	$645K	Hold	1,329	–	–	0.18%	57
2025 Q2	$539K	Hold	1,329	–	–	0.16%	68
2025 Q1	$661K	Hold	1,329	–	–	0.21%	54
2024 Q4	$691K	Hold	1,329	–	–	0.21%	59
2024 Q3	$822K	Hold	1,329	–	–	0.24%	60
2024 Q2	$735K	Hold	1,329	–	–	0.22%	63
2024 Q1	$772K	Hold	1,329	–	–	0.23%	61
2023 Q4	$705K	Hold	1,329	–	–	0.22%	70
2023 Q3	$673K	Hold	1,329	–	–	0.24%	70
2023 Q2	$693K	Sell	1,329 -108	-8%	-$58.3K	0.25%	66
2023 Q1	$828K	Sell	1,437 -235	-14%	-$132K	0.32%	50
2022 Q4	$921K	Hold	1,672	–	–	0.37%	40
2022 Q3	$848K	Sell	1,672 -93	-5%	-$52K	0.41%	38
2022 Q2	$959K	Buy	1,765 +93	+6%	+$51.2K	0.44%	37
2022 Q1	$988K	Hold	1,672	–	–	0.39%	43
2021 Q4	$1.12M	Hold	1,672	–	–	0.41%	50
2021 Q3	$955K	Hold	1,672	–	–	0.38%	53
2021 Q2	$843K	Hold	1,672	–	–	0.32%	66
2021 Q1	$763K	Sell	1,672 -383	-19%	-$183K	0.3%	70
2020 Q4	$957K	Hold	2,055	–	–	0.41%	58
2020 Q3	$907K	Sell	2,055 -81	-4%	-$33.5K	0.44%	48
2020 Q2	$774K	Hold	2,136	–	–	0.36%	64
2020 Q1	$606K	Hold	2,136	–	–	0.32%	69
2019 Q4	$694K	Sell	2,136 -1	-0%	-$303	0.32%	72
2019 Q3	$622K	Hold	2,137	–	–	0.33%	71
2019 Q2	$628K	Buy	2,137 +1	+0%	+$275	0.33%	74
2019 Q1	$585K	Buy	+2,136	New	+$532K	0.33%	75

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Covenant Partners's TMO Position: Q1 2026 in Review

Covenant Partners sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 1,344 shares — an estimated $779K sold.

Covenant Partners first reported a position in TMO in Q1 2019 and held it in 28 quarters. The position peaked at $1.12M in Q4 2021. 2,600 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Covenant Partners reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
Covenant Partners sold 1,344 Thermo Fisher Scientific shares in Q1 2026, an estimated $779K.
Covenant Partners first reported a position in Thermo Fisher Scientific in Q1 2019 and held it in 28 quarters.
Covenant Partners's Thermo Fisher Scientific position peaked at $1.12M in Q4 2021.
2,600 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Covenant Partners's 13F filing for Q1 2026.